Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;55(9):2183-2191.
doi: 10.1007/s11255-023-03659-1. Epub 2023 Jun 18.

Activation of the adenosine A1 receptor in the lumbosacral spinal cord improves bladder overactivity in rats with cystitis induced by cyclophosphamide

Affiliations

Activation of the adenosine A1 receptor in the lumbosacral spinal cord improves bladder overactivity in rats with cystitis induced by cyclophosphamide

Lin Zhang et al. Int Urol Nephrol. 2023 Sep.

Abstract

Purpose: To investigate the effect of intrathecal administration of CCPA, an adenosine A1 receptor agonist, on voiding function in rats with cystitis induced by cyclophosphamide (CYP).

Methods: Thirty 8-week-old Sprague Dawley rats were randomly divided into a control group (n = 15) and a cystitis group (n = 15). Cystitis was induced by a single intraperitoneal injection of CYP (200 mg/kg, dissolved in physiological saline) in rats. Control rats were injected intraperitoneally with physiological saline. The PE10 catheter reached the level of L6-S1 spinal cord through L3-4 intervertebral space for intrathecal injection. Forty-eight hours after intraperitoneal injection, urodynamic tests were conducted to observe the effect of intrathecal administration of 10% dimethylsulfoxide (vehicle) and 1 nmol CCPA on micturition parameters, including basal pressure (BP), threshold pressure (TP), maximal voiding pressure (MVP), intercontraction interval (ICI), voided volume (VV), residual volume (RV), bladder capacity (BC), and voiding efficiency (VE). Histological changes of the bladder of cystitis rats were studied through hematoxylin-eosin staining (HE staining). Moreover, Western blot and immunofluorescence were used to study the expression of adenosine A1 receptor in the L6-S1 dorsal spinal cord in both groups of rats.

Results: HE staining revealed submucosal hemorrhage, edema, and inflammatory cell infiltration in the bladder wall of cystitis rats. The urodynamic test showed significant increase in BP, TP, MVP and RV in cystitis rats, while ICI, VV, BC and VE decreased significantly, indicating bladder overactivity. CCPA inhibited the micturition reflex in both control and cystitis rats, and significantly increased TP, ICI, VV, BC, and VE, but had no significant effect on BP, MVP and RV. Western blot and immunofluorescence showed that there was no significant difference in the expression of adenosine A1 receptor in the L6-S1 dorsal spinal cord between the control and cystitis rats.

Conclusion: The findings of this study suggest that intrathecal administration of the adenosine A1 receptor agonist CCPA alleviates CYP-induced bladder overactivity. Furthermore, our results indicate that the adenosine A1 receptor in the lumbosacral spinal cord may be a promising target for treatment of bladder overactivity.

Keywords: Adenosine A1 receptor; Bladder overactivity; Cyclophosphamide; Cystitis; Lumbosacral spinal cord.

PubMed Disclaimer

References

    1. Lin HY, Lu JH, Chuang SM, Chueh KS, Juan TJ, Liu YC, Juan YS (2021) Urinary biomarkers in interstitial cystitis/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics (Basel). https://doi.org/10.3390/diagnostics12010075 - DOI - PubMed - PMC
    1. Grundy L, Caldwell A, Brierley SM (2018) Mechanisms underlying overactive bladder and interstitial cystitis/painful bladder syndrome. Front Neurosci 12:931. https://doi.org/10.3389/fnins.2018.00931 - DOI - PubMed - PMC
    1. Yoshikawa S, Oguchi T, Funahashi Y, de Groat WC, Yoshimura N (2012) Glycine transporter type 2 (glyt2) inhibitor ameliorates bladder overactivity and nociceptive behavior in rats. Eur Urol 62(4):704–712. https://doi.org/10.1016/j.eururo.2012.01.044 - DOI - PubMed - PMC
    1. Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78(4):661–671. https://doi.org/10.1007/s00280-016-3152-1 - DOI - PubMed
    1. Teles KA, Medeiros-Souza P, Lima F, Araujo BG, Lima R (2017) Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review. Rev Bras Reumatol Engl Ed 57(6):596–604. https://doi.org/10.1016/j.rbre.2016.09.008 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources